Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial

Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation), Sahil A. Parikh(NewYork–Presbyterian Hospital), Richard L. Snider, Deepak L. Bhatt(Mount Sinai Hospital), Subhash Banerjee(Baylor University Medical Center), Kristine Owen, Judit Karácsonyi(University of Utah), Milton V. Icenogle(University of New Mexico), T. Conner, Peter C. Block(Emory University Hospital Midtown), Sunil V. Rao(New York University), Bavana V. Rangan(Minneapolis Heart Institute Foundation), Santiago García(Minneapolis VA Health Care System), Michael P. Thomas(University of Michigan), On Topaz(Duke University), Todd H. Wagner(VA Palo Alto Health Care System), Hani Jneid(The University of Texas MD Anderson Cancer Center), Mohammed Osman, Kodangudi B. Ramanathan, Hiram G. Bezerra, Steven Goldman(University of Arizona), Mark J Ricciardi, Robert Edson(Program Support Center), Kendrick Shunk(San Francisco VA Medical Center), Joseph Jozic, Brahmajee K. Nallamothu(University of Michigan), Ying Lü(University of Illinois Urbana-Champaign), Faisal Latif, Lauren Uyeda(Program Support Center), D Michelle Ratliff, Paul Grossman(Michigan Medicine), Bina Ahmed, Aaron Alsleben(Program Support Center), Hitinder S. Gurm(University of Michigan), Kreton Mavromatis, Ehrin J. Armstrong(University of Denver), Amer Ardati(University of Illinois Chicago), Anthony A. Bavry(University of Florida), Daniel Menees, David R. Holmes(Mayo Clinic in Florida), Jonathan Goldberg, Gautam Kumar(Atlanta VA Medical Center), Mei‐Chiung Shih(Stanford University), David A. Zidar(Mayo Clinic), Mark Sheldon, Beverly Ventura(Program Support Center), José Ortiz, Claire S. Duvernoy
The Lancet
May 1, 2018
Cited by 84


Related Papers